ResearcherNational Chung Hsing UniversityNo recent work listed

Ying‐Yin Chen

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5077863021. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 2 papers

Papers 2

Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells. Co-author DOI 10.1002/ptr.7385 ↗
4-Acetylantroquinonol B enhances cell death and inhibits autophagy by downregulating the PI3K/Akt/MDR1 pathway in gemcitabine-resistant pancreatic cancer cells. Co-author DOI 10.3892/ol.2022.13248 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gow‐Chin Yen · 2 shared papers, 2022 · strength 0.37
- Paper Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells. DOI 10.1002/ptr.7385 ↗
- Paper 4-Acetylantroquinonol B enhances cell death and inhibits autophagy by downregulating the PI3K/Akt/MDR1 pathway in gemci… DOI 10.3892/ol.2022.13248 ↗
Yi‐Hao Hsu · 1 shared paper, 2022 · strength 0.19
- Paper Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells. DOI 10.1002/ptr.7385 ↗
Sheng‐Yi Chen · 1 shared paper, 2022 · strength 0.19
- Paper Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells. DOI 10.1002/ptr.7385 ↗
Chin‐Chu Chen · 1 shared paper, 2022 · strength 0.19
- Paper 4-Acetylantroquinonol B enhances cell death and inhibits autophagy by downregulating the PI3K/Akt/MDR1 pathway in gemci… DOI 10.3892/ol.2022.13248 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.